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Background
Historical data (1) reveal well-documented air
pollution episodes that led to deaths, the
majority of which occurred among individu-
als with known cardiovascular and respiratory
disease. During a 5-day fog in December
1930, 63 people died in the Meuse Valley in
Belgium, with most deaths occurring on days
4 and 5 of the episode. Older persons with
previously known diseases of the heart or
lungs accounted for the majority of fatalities.
In Donora, Pennsylvania, 20 people died and
approximately 7,000 experienced acute illness
in October 1948; people 55 years of age and
older were most severely affected. The
episode in London in December 1952
resulted in at least 4,000 extra deaths, the
greatest increase being in those 45 years of
age and older. Therefore, it has long been sus-
pected that particulate pollution may precipi-
tate premature death not only from lung but
also from heart disease. In the last decade it
has become apparent this is still true, even at
the much lower particle concentrations preva-
lent today. Moreover, there is also evidence
that life in a polluted climate may contribute
to long-term risks of death from heart disease.
It is not intuitively obvious how low concen-
trations of particles in the lung could cause
such effects on another organ. This has led
some to question the causative conclusions
drawn from the epidemiologic observations.
In 1995 we proposed a hypothetical mecha-
nism whereby particles reaching the lung lin-
ing cells could influence blood coagulability
and thus lead to heart disease (2). Our
hypothesis required addressing two mysteries.
First, why should the pulmonary and sys-
temic effects be evident at such low airborne
mass concentrations compared to, for exam-
ple, the U.K. occupational nuisance dust
standard. Second, how could such concentra-
tions influence the cardiovascular system as
well as the lung? In answering the first, we
suggested that the number and possibly the
surface area rather then the mass concentra-
tion of particles were driving the effect. In
answering the second, we proposed that lung
inflammation might have effects on blood
coagulability, which in turn could provoke
myocardial infarction. In the present article
we review subsequent investigations of these
and related hypothetical mechanisms for the
effects of particulate matter with a mass
median aerodynamic diameter less than 10
µm (PM10) on the cardiovascular system. We
focus especially on ultraﬁne particles because
they have been a major part of our research. 
Acute versus Chronic Effects
The effects of ambient particles in epidemio-
logic studies are conventionally considered to
be either acute, seen in time-series studies or
chronic, seen in cohort studies. In this article
we describe both chronic and acute effects
together, as the underlying mechanisms are the
unifying factor in this review. Furthermore,
the effects under discussion are largely specula-
tive, at least regarding mechanism, and it is dif-
ficult to define the nature of acute versus
chronic. There is reason, for example, to
believe that multiple low-level acute effects
would culminate in a chronic effect. However,
Table 1 classiﬁes the potential cardiovascular
effects of particles fairly arbitrarily as chronic
or acute. 
Ultraﬁne Particles 
in Ambient Air
There is ample evidence that a small proportion
by mass but a large proportion by number of
the particles in ambient air are ultrafine in
size, i.e., less than 100 nm in diameter (3–5).
It has been suggested (6–8) that the ultraﬁne
component of PM10 may mediate some of the
adverse health effects reported in epidemio-
logic studies of the relationship between expo-
sure to environmental particles and adverse
health effects. Considerable toxicologic evi-
dence supports the idea that ultraﬁne particles
have special toxicity compared to the same
material as larger particles (9). Other compo-
nents of PM, such as transition metals and
endotoxin, could mediate adverse effects, but
these are not discussed extensively here. 
The very small (< 50 nm) nucleation
particles generated directly by combustion
and photochemical activity are unstable and
persist only brieﬂy as singlet particles, aggre-
gating to form larger accumulation particles.
These particles range in size from a few tens
of nanometers up to a micrometer or so
(10). Ultrafine particles from all sources
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aggregate readily if produced at a sufficient
concentration. They may also adhere to the
surface of larger nonultraﬁne particles to form
heterogeneous aggregates. Some of these
accumulation particles would not be ultraﬁne
by the < 100 nm convention, but each would
comprise ultraﬁne particles. This leads to the
questions, does this aggregation lead to loss of
toxicity, or do the larger particles retain the
toxicity of their component ultraﬁnes? And, if
the latter, what is the mechanism? One obvi-
ous possibility is that they disaggregate on
deposition in the lung to release individual
particles that then act as if they had been
inhaled as singlets. Aggregates of ultrafine
particles of carbon black instilled into the
lungs of rats have been shown to generate
more inﬂammation than aggregates of nonul-
traﬁne carbon black (11,12). This increase in
toxicity may be a consequence either of disag-
gregation into singlet particles or of the abil-
ity of particles in aggregates to continue to
exert effects via a large surface area.
Because most exposures occur indoors,
the contribution of indoor-derived particles
such as environmental tobacco smoke could
potentially produce the effects described in
this review.
Oxidative Stress Caused 
by Particles
Pathogenic Particles in General
There is extensive evidence that particles of
various sorts associated with lung disease, e.g.,
asbestos, coal mine dust, quartz, cause oxida-
tive stress in cell-free systems in exposed cells
and in lungs of rats after experimental expo-
sure (13). There is a link between oxidative
stress and inflammation via activation of
oxidative stress-responsive transcription fac-
tors such as nuclear factor kappa B (NF-κ B)
and activator protein 1, which control proin-
flammatory genes via redox changes within
the cell (14). 
PM10 and PM2.5
There is accumulating evidence that PM10
and PM with a mass median areodynamic
diameter less than 2.5 µm (PM2.5) also have
intrinsic ability to cause oxidative stress in
cell-free systems (15) in cells exposed in vitro
(16,17) and in exposed animals (18,19). The
mechanism of this oxidative stress is considered
to be mediated by transition metals, as shown
by a number of studies (15,17,19).
Transition metals, derived from fuel
combustion, are present in PM along with
ultrafines. The relative importance of these
two potential pathogenic factors is unclear,
i.e., it is not clear whether there can be gener-
ation of oxidative stress and inflammation
from ultrafines by mechanisms other than
their ability to release transition metals and
subsequently generate a Fenton reaction in
the lung milieu. Understanding such mecha-
nisms is of more than theoretical importance;
future control of the adverse effects of partic-
ulate pollution will depend on an under-
standing of the toxic components in order to
set appropriate standards. Such standards, at
least in theory, might be based on particle
numbers, numbers below a certain diameter,
surface area, or any component of the particle
such as metal content.
Ultraﬁne Particles 
We have investigated ultrafine particles of
carbon black [(ufCB); 14 nm primary parti-
cle diameter] that we had previously shown
to have greater inflammogenicity than
nonultraﬁne respirable CB (260 nm primary
diameter) at low lung dose following instilla-
tion (11,12,20). ufCB also causes more
oxidative stress than the same mass of fine
CB to cells in culture, as measured by
reduced glutathione (GSH) levels. 
We have investigated whether transition
metals are responsible for the additional abil-
ity of ufCB to cause inﬂammation compared
to CB at the same mass dose. Treatment of
the ufCB with a transition metal chelator, a
maneuver that decreases the oxidative activity
of PM10 (21), had no effect on the ability of
ufCB to cause inﬂammation in rat lungs (12).
Moreover, the soluble fraction collected from
the ufCB particles, which contains all the
oxidative (21) and inﬂammogenic (19) poten-
tial of some PM samples, did not itself cause
inflammation (12). We deduce from these
experiments that ultrafine particles of some
types, including CB, can cause inﬂammation
via nontransition metal-mediated pathways. 
The mechanism of the generation of
oxidative stress is unknown, but studies with
the dye dichloroﬂuorescein, which ﬂuoresces
in the presence of oxidants, have shown that
ufCB has much more surface free radical
activity than nonultrafine CB, suggesting a
direct generation of oxidative stress at the
particle surface (22). 
There are chemical reasons for supposing
that very small particles may have much more
reactive surfaces than the same material in
larger form, because of rearrangement of their
surface atoms in order to maintain their
structure. Whatever the precise mechanisms,
evidence to date suggests that both a factor
associated with the size of particles and also
the transition metals contained in them may
act separately as mediators of lung injury.
Modulation of Intracellular Calcium as
a Mode of Action of Ultraﬁne Particles 
The various adverse health effects induced by
exposure to PM are likely to involve the
upregulation of proinflammatory mediators
such as cytokines and chemokines. The intra-
cellular pathways by which PM, transition
metals, and ultrafine particles modulate the
gene expression of proinflammatory media-
tors are uncertain. 
Recent studies reveal that noncytotoxic
doses of ufCB and ultrafine latex particles
induce alterations in calcium signaling in
both human monocytic cell lines and in rat
bronchoalveolar lavage cells (> 85%
macrophages) (23,24). Intracellular calcium is
involved in the control of inflammatory
responses to conditions such as sepsis (25), as
well as in the control of transcription factors
such as NF-κ B and nuclear factor of activated
T cells (26).
Interestingly, ultraﬁne particles have only a
small, but significant, effect on the resting
cytosolic calcium concentration of macro-
phages (24). The full effect of the ultraﬁne par-
ticles on macrophages was not observed until a
second stimulus, thapsigargin, which releases
endoplasmic reticulum calcium stores, was
added. In releasing these intracellular stores,
thapsigargin, like inositol 1,4,5-trisphosphate,
initiates an inﬂux of extracellular calcium via
plasma membrane calcium channels. The
ultrafine particles enhanced this “calcium
release–activated calcium current” across the
plasma membrane by as much as 2.5-fold
(23,24). These data suggest that in the pres-
ence of a second stimulus, for example, a
proinﬂammatory mediator, ultraﬁne particles
can have a substantial effect on intracellular
calcium-signaling pathways and, potentially,
on expression of proinflammatory genes.
Hence, susceptible individuals, including those
with preexisting inﬂammation, may be more
responsive to PM exposure because they are
already primed for calcium stimulation by
cytokines in the inﬂammatory milieu. Priming
of type II epithelial cell lines by tumor necrosis
factor-α (TNF-α) enhances the interleukin
(IL)-8 production of these cells in response to
residual oil ﬂy ash or quartz exposure (27).
The exact mechanism by which ultraﬁne
particles are able to enhance calcium influx
on stimulation of the macrophages is
unknown; however, addition of antioxidants
such as nacystelin or mannitol partially inhib-
ited the response (23), indicating a role for
reactive oxygen species in this pathway. In
view of the central role that calcium plays in
the functions of cells, such ﬁndings lead to a
Table 1. Postulated effects of particles on the cardiovas-
cular system classiﬁed as to the time scale of the effect.
Effect Time  scale
APR Acute
Atherogenesis Chronic
Atheromatous plaque  Acute/chronic
destabilization/rupture 
Thrombogenesis Acute 
Cardiac arrhythmia  Acute 
Heart rate variability  Acute or chronicCardiovascular effects of particle inhalation
better understanding of the mode of action
of ultraﬁnes.
Oxidative Stress and the
Cardiovascular System
Oxidative stress in the lungs following particle
exposure is to be anticipated for the reasons
mentioned above. It is likely to arise first at
the particle surface and then be augmented
by oxidants generated by any recruited
inﬂammatory leukocytes. It is central to this
review to consider what impact the genera-
tion of oxidative stress in the lungs might
have for the cardiovascular system.
Increased Airspace Epithelial
Permeability 
An important consideration is that oxidative
stress, and especially depletion of reduced
GSH, can increase the permeability of the
lung epithelium (28), allowing passage of par-
ticles and particle-loaded macrophages into
the interstitium. This could allow particles
access to the endothelial cells, the blood, and
potentially even to be transported to other
organs, although presently there is little evi-
dence to support this. Increased epithelial
permeability may also allow diffusible mole-
cules produced in the lungs in response to
particles to enter the interstitium and possibly
gain access to the circulation. These media-
tors could include those shown in Table 2
and could have the effects shown.
Atheromatous Plaques
Atheromatous plaques form in arteries, and in
the coronary arteries are the underlying
lesions leading to angina and myocardial
infarction, causes of morbidity and death
associated epidemiologically with particulate
air pollution. We can differentiate between
chronic effects on atheroma formation and
development, and acute events that lead to
plaque rupture. Plaque formation is acceler-
ated by increased low-density lipoprotein
(LDL) cholesterol [and decreased high-
density lipoprotein (HDL) cholesterol],
smoking, increased vasoactive amines, diets
low in fruit and vegetables and high in fat
(particularly saturated fat), lack of physical
activity, and genetic predisposition. Many of
these risk factors, such as the intensity of
exposure to air pollution, are associated with
socioeconomic deprivation. Increased oxida-
tion of LDL is a key feature of foam cell and
atheroma development, and transition metals
can enhance both direct LDL oxidation (29)
and oxidation of LDL by monocytes (30). It
is possible, therefore, that transition metal-
derived oxidants or other oxidative activity
generated by particles could oxidize LDL and
this could be proatherogenic.
Plaques typically contain inflammatory
cells, smooth muscle cells, foam cells, and a
lipid-rich core capped by a fibrous layer of
connective tissue and fibroblasts (31). The
lipid core of the plaque is highly thrombo-
genic, and when the plaque ruptures, throm-
bosis in the vessel commonly results, leading
to infarction (31,32). The production and
release of acute phase reactants, such as C-
reactive protein (CRP), as a result of increased
inﬂammation have been proposed as a marker
of unstable atheromatous plaques and under-
lying atherosclerosis (33). Thrombosis may
also arise from plaque endothelial erosion
when there is denudation of the overlying
endothelium exposing the basement mem-
brane (31). Thrombus forms against this and
adheres to the surface of the plaque. Any effect
of particle deposition in the lung that favors
either endothelial erosion, plaque rupture, or
production of clotting factors would increase
the likelihood of a thrombus forming. 
The Acute-Phase Response
(APR) 
APR and the Clotting System 
In response to our original suggestion that air
pollution effects on the heart were mediated
by increases in blood coagulability, Peters et
al. (34) investigated plasma viscosity, which is
determined largely by plasma ﬁbrinogen con-
centration, in a population in relation to a
severe air pollution episode. They found that
viscosity was higher during the incident, sug-
gesting that the pollution might have been
responsible. More recently, they have shown
that increases in heart rate in response to air
pollution are most marked in individuals who
have high blood viscosity, perhaps deﬁning a
susceptible group (34). Prescott et al. (35) also
reported that people with high concentrations
of plasma ﬁbrinogen might be more suscepti-
ble to the adverse cardiovascular effects of par-
ticulate air pollution. Estimates of interaction
of ﬁbrinogen with a binary indicator of black
smoke pollution were 1.15 (conﬁdence inter-
val 0.93–1.44; p = 0.2), so limitations of
power meant that evidence relating this inter-
action was not conclusive. In contrast, our
own study of elderly individuals found no
signiﬁcant changes in ﬁbrinogen or factor VII
in relation to exposure to particles over a year,
although we did ﬁnd rises in CRP, an index of
inflammation, and falls in platelets and red
blood cells in relation to rises in PM10 (36).
These results suggested an effect of particles
on endothelial function, leading to sequestra-
tion of red cells and platelets, a response that
could theoretically impair circulation and pro-
mote thrombosis.
Ghio and co-workers report increased
bronchoalveolar lavage neutrophils and blood
fibrinogen after inhalation of concentrated
ambient particles (CAPs) at exposures that
ranged from 23.1 to 311.1 µg/m3 (37). 
Fibrinogen, CRP, and factor VII are part
of the acute-phase response, which is medi-
ated by cytokines released during inﬂamma-
tory reactions. Increases in any proteins of
the clotting cascade present an increased pos-
sibility of coagulation. In addition, raised
concentrations of fibrinogen and factor VII
are recognized long-term risk factors for
myocardial infarction. 
We have found increases in factor VII in
rats following a short exposure to ufCB but
no such effect with nonultrafine CB (38).
However, we found no increase in ﬁbrinogen
up to 7 days postexposure to ufCB in these
experiments. Factor VII could be produced in
the liver by mediator signals from the lungs
or could be made in the lungs in situ by
macrophages (39). 
APR and cardiovascular disease. CRP is
an acute-phase protein produced in the liver
in response to injury, infection, or other
inflammatory stimuli (40). Studies have
shown a positive association between CRP
and coronary artery disease (41,42). In a sur-
vey of 388 British men 50–69 years of age,
the prevalence of coronary artery disease
increased 1.5-fold for each doubling of CRP
level (42). We have shown an association
between increases in PM10 and elevation of
plasma CRP (36). The explanation of the
association of coronary artery disease with
CRP is thought to be in the atherogenic
effects of chronic inflammation (42,43),
although it is conceivable that the increase is
due to cytokines released by cells in the
plaques of people with extensive atheroma. 
CRP in plaques. If raised, CRP is per se
a risk factor for cardiovascular disease.
Moreover, it appears to increase in association
with PM10 exposure, and there could be a
link between these two observations.
Increased CRP could increase as a conse-
quence of plaque instability but might also
contribute to it. Certainly, CRP has been
found in plaques, and from its disposition it
has been hypothesized that it facilitates the
uptake of lipids by macrophages accumulat-
ing in atherosclerotic lesions (44). It has also
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Table 2. Mediators from lung cells that could have systemic effects.
Mediator  Lung cell of origin  Likely systemic effect
IL-1, IL-6, TNF-α Macrophages, epithelial cells  APR 
Fibrinogen Epithelial  cells  Procoagulant 
Factor VII  Lung macrophages  Procoagulant 
Oxidized LDL  Lung lining ﬂuid  Atherogenic Donaldson et al.
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been suggested that it might participate both
in cytolysis, enlarging the necrotic area in
plaques, and/or in the phagocytic scavenging
of the necrotic tissue. (44). Facilitating
uptake of lipid and enlarging necrotic areas in
plaques could be seen as contributing to their
instability. Enzymatic modiﬁcation of tissue-
deposited LDL confers CRP-binding capacity
on the molecule, which enhances comple-
ment activation; this could lead directly to
recruitment of cells and enhanced inﬂamma-
tion in plaques, which leads to destabilization
(45). Such enzymatic modiﬁcation could arise
from leukocyte proteases released from cells
in the plaque. 
Although CRP may contribute to plaque
instability, it also has well-documented anti-
inﬂammatory effects. There may be a temporal
relationship in the pro- and anti-inﬂammatory
properties of CRP that depends on the various
microenvironments (such as acidity and pro-
teolytic activity) it experiences during the
evolution of an inﬂammatory focus (46).
As noted above, we have reported
increased CRP in association with rises in city
center PM10 (36). This suggests that particles
are able to stimulate APR. In individuals with
pre-existing high CRP and already at risk,
increases in PM10 may increase the likelihood
of plaque destabilization and rupture by fur-
ther elevating CRP. The mechanism for CRP
increase is likely to be the production of the
APR, with cytokines produced in the lung
passing to the liver and stimulating CRP pro-
duction. Individuals with unstable plaques
and with increased CRP as a marker of these
events may thus have a further increase by
deposition of particles. 
Although direct transport of particles or
components of PM such as ultrafine parti-
cles or metals to the liver cannot as yet be
ruled out, it seems unlikely that a biologi-
cally sufficient concentration would reach
the cells of the target organ after dilution in
the circulation. 
It is notable that CAPs alone have little
effect on blood indices, as shown by Clarke et
al. (47) in dogs, although the concentrator
used in the study does not concentrate ultra-
ﬁne particles.
Interactions between particles and CRP.
In addition to being a marker of risk, a mech-
anism for CRP as a pathogenic factor in par-
ticle-exposed individuals comes from the
known effects of CRP. If deposition of parti-
cles in the lungs during high PM episodes
causes even mild inflammation, there could
be increased permeability that would allow
CRP to enter the lungs more readily from
plasma, although increases in lung lining
fluid CRP could also arise from alveolar
macrophage production of CRP (48). The
presence of CRP could modify the response
to particles such that it enhances their ability
to cause inflammation. An obvious way this
could arise is via the complement-activating
effects of CRP (49). Any enhanced produc-
tion of C5a could lead to increased chemoat-
traction of cells to the particle-exposed lungs.
CRP bound to particles could also be an
important modiﬁer of the interaction of CRP
with the complement system inflammatory
response, as CRP has been reported to change
its activity on becoming surface bound (46).
There could also be direct effects from
oxidative activities of particles or their associ-
ated metals. Human CRP has been shown to
acquire the ability to augment platelet reactiv-
ity when treated with a transition metal-ascor-
bate system that generates reactive oxygen
intermediates (50). CRP modified by such
treatment showed no appreciable activation of
platelets in the absence of platelet activators
such as platelet-activating factor, thrombin, or
adenosine diphosphate; but in the presence of
the modified CRP, irreversible activation of
platelets occurred with low doses of platelet-
activating factor and other stimulatory agents.
Moreover, proteolytic fragments of CRP are
associated with activation of alveolar macro-
phage TNF-α and macrophage chemotactic
protein-1 production and upregulation of
adhesion molecules (51). Such proteolysis
could be mediated by lung macrophages
attempting to phagocytose particles and there-
fore could be of potential importance in form-
ing an exaggerated response. More research on
the role of CRP in modifying the lung’s
response to particles is warranted. 
Evidence of Systemic Oxidative 
Stress in Susceptible Populations 
and After Particles
Evidence indicates that systemic oxidative
stress does occur in groups at risk from the
adverse effects of PM. Rahman and MacNee
(52) have shown decreases in Trolox equiva-
lent antioxidant capacity (TEAC), a global
measure of plasma antioxidant capacity that
assesses all antioxidants including GSH, vita-
min C, and vitamin E but does not discrimi-
nate between them, in the plasma of patients
with chronic obstructive pulmonary disease,
asthma, and those who smoke. We have also
reported that instillation of PM10 (11) and
inhalation of ufCB at 1 mg/m3 for 7 hr,
decreased plasma TEAC in rats (53), demon-
strating systemic oxidative stress. The elderly
have been identified as being at risk from
PM10, and one study in asymptomatic elderly
nuns has shown that those with increased
CRP, suggesting the presence of an inﬂamma-
tory reaction, showed a decreased antioxidant
proﬁle in plasma (54 ). Such individuals could
be susceptible to PM, as they already have
oxidative stress that could be augmented by
further stress from particles. The critically ill
are also a potential target for the effects of
PM10. Increased oxidative stress has been
observed in individuals with, for example, sep-
sis, shock, the need for mechanical ventilation,
organ dysfunction, acute respiratory distress
syndrome, and disseminated intravascular
coagulation. Similar changes have also been
noted in patients following surgery and in the
presence of an acute-phase response (55). 
An animal model of cardiovascular disease
(56), the spontaneously hypertensive rat, had
higher basal levels of oxidative stress, measur-
able as bronchoalveolar lavage thiobarbituric
acid derivatives, than normal rats. On chal-
lenge with residual oil fly ash there was
greater injury in the hypertensive rats; they
had an attenuated antioxidant response which
may have contributed to injury. This sup-
ports the contention that cardiovascular dis-
ease patients may have oxidative stress that is
a susceptibility factor for particle effects.
Conclusion
Good toxicologic evidence supports the
contention that PM acts in the lung to cause
oxidative stress, and the epidemiologic evi-
dence provides the toxicologist with clues as
to mechanisms for the adverse actions of PM
on the cardiovascular system. In this review
we have sought to bring these findings
together, suggesting pathobiologic processes
whereby PM, and especially the ultrafine
component, might have effects on the cardio-
vascular system (Figure 1). Pathologic end
points relevant to plaque rupture, endothelial
erosion, hemostasis, and coagulation should
be used in toxicologic studies. Transition
metals could have essentially the same effects
as ultrafine particles in generating oxidative
stress and adversely affecting the cardiovascu-
lar system. The relative importance of the
components of PM such as ultraﬁne particles
and transition metals in causing the various
known effects of PM requires considerable
further research effort.
Figure 1. Diagram of the hypothetical events leading
from deposition of particles in the lungs to ischemic
events.
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